Antimicrobial resistance is a serious health threat that affects the clinical outcome of patients and also results in higher rates of adverse events and healthcare costs. The discovery of potent antimicrobial agents was one of the greatest contributions to medicine in the 20th century. Unfortunately, the emergence of antimicrobial-resistant pathogens now threatens these advances. Antimicrobial resistance affects everybody and knows no geographic boundaries—a resistant deadly pathogen may be just a plane ride away.
Immunizations are an essential component of disease prevention and control. Preventing healthcare-associated transmission of infectious diseases protects patients, HCPs, their families, and their communities.
You’ve heard it on the news, from your doctors, and even from a few friends: Now is the time to get the annual influenza (flu) vaccine. Although the Centers for Disease Control and Prevention (CDC) recommends that everyone 6 months and older should receive an annual flu vaccine, many people fail to understand why and where this recommendation came from, and why an annual flu vaccine is so important.
Advances in science and technology are giving rise to research and development for new vaccines. Additionally, innovative manufacturing approaches are being applied in the production of these products. This is especially true for vaccines necessary to address global patient population needs in developing countries and international markets.
Standing Orders Programs provide a proven solution to improve low adult immunization rates, improve clinic efficiency, and reduce barriers to providing adult vaccines. Successful implementation will improve the quality of patient care while concurrently reducing the logistical burdens of providing adult vaccines.
Through its many strategic partnerships, NFID works with a wide range of organizations to reduce the burden of infectious diseases in the US and amplify important messaging with ‘one strong voice.’
Parents usually rely on their child’s pediatrician to keep them up-to-date on vaccines. But the updated meningococcal vaccine recommendation recently issued by the Centers for Disease Control and Prevention (CDC) is different. The new recommendation paves the way for adolescents and young adults to get vaccinated against a rare, but deadly infection called serogroup B meningococcal disease–but it puts more responsibility on parents to seek and request the vaccine.